Kaposi Sarcoma Market - Global Industry
Analysis, Size, Share, Growth, Trends and
Forecast 2014 - 2020
Single User License:
Transparency Market Research
90, State Street, Suite 700.
Albany, NY 12207
Flat 10% Discount!!
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
Report will be delivered with in 15-20 working days
Kaposi’s sarcoma is a cancer that develops from the cell that line in the lymph or blood vessel. Kaposi’s sarcoma grows in the lining of mouth,
throat, nose and other organs in our body such as the lymph nodes, lungs and digestive tract. This type of sarcoma is made up of cancer and
blood cells that causes purple, red or brown blotches or tumors on the skin. Sometimes Kaposi’s sarcoma can spread to the digestive tract or
lungs that may create emergency life threatening conditions. The most common symptom for Kaposi’s sarcoma includes bloody sputum and
shortness of breath. A patient who is suffering from cancer and who had radiotherapy for another cancer are at high risk for suffering from Kaposi’s
sarcoma. Moreover, people with AIDS are also at a high risk for developing Kaposi’s sarcoma. Kaposi’s sarcoma can be diagnosed with radiation
therapy, proton therapy, computed tomography, positron emission tomography and tissue biopsy. Possible treatment option for Kaposi’s sarcoma
includes chemotherapy, cryotherapy and radiation therapy.
According to American Cancer Society Kaposi’s sarcoma can be classified as:
Epidemic (AIDS-related) Kaposi’s sarcoma
Classic (Mediterranean) Kaposi’s sarcoma
Endemic (African) Kaposi’s sarcoma
Iatrogenic (transplant-related) Kaposi’s sarcoma
Kaposi’s sarcoma in HIV negative men
Browse Full Report With TOC:-...